Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BMS signs $475m licensing deal with Dragonfly Therapeutics

pharmaceutical-technologyAugust 19, 2020

Tag: BMS , Dragonfly Therapeutics , IL-12 , DF6002

PharmaSources Customer Service